Pulse Biosciences(PLSE) - 2025 Q4 - Annual Report
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) Securities registered pursuant to Section 12(b) of the Act: | | | Registered | | --- | --- | --- | | Title of Each Class Common Stock, par value $0.001 per share | Trading Symbol(s) PLSE | Name of Each Exchange on Which The Nasdaq Stock Market LLC | ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 Or ☐ TRANSITION REPO ...